摘要
Pancreatic cancer,which develops rapidly,is a common type of malignant tumors found in the digestive tract.According to the latest data from the American Cancer Society in 2022,pancreatic cancer ranks as the fourth leading cause of cancer death for new-onset cancers globally,the tenth for men,and the seventh for women.Despite rapid advances in precision medicine and improved survival rates for other types of cancer,the current outcomes of pancreatic cancer treatment regimens remain poor.
